These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22234937)

  • 1. Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12.
    Amlin-Van Schaick JC; Kim S; DiFabio C; Lee MH; Broman KW; Reilly KM
    Neuro Oncol; 2012 Feb; 14(2):160-74. PubMed ID: 22234937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5.
    Amlin-Van Schaick J; Kim S; Broman KW; Reilly KM
    Mamm Genome; 2012 Apr; 23(3-4):277-85. PubMed ID: 22160242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
    Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner.
    Walrath JC; Fox K; Truffer E; Gregory Alvord W; Quiñones OA; Reilly KM
    Mamm Genome; 2009 Apr; 20(4):214-23. PubMed ID: 19347398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects.
    Reilly KM; Tuskan RG; Christy E; Loisel DA; Ledger J; Bronson RT; Smith CD; Tsang S; Munroe DJ; Jacks T
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):13008-13. PubMed ID: 15319471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of astrocytoma and glioblastoma multiforme.
    Van de Kelft E
    Acta Neurochir (Wien); 1997; 139(7):589-99. PubMed ID: 9265950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of Glioblastoma.
    Bhawe K; Felty Q; Yoo C; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Roy D
    Mol Neurobiol; 2020 Sep; 57(9):3827-3845. PubMed ID: 32594352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
    Huang S; Qi P; Zhang T; Li F; He X
    Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genetic markers of the glial tumor by means of differential display technique.
    Comincini S; Capelli E; Cattana E; Zanoli E; Ceroni M; Nano R
    Anticancer Res; 1999; 19(1A):277-80. PubMed ID: 10226554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
    Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB
    J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
    Narsia N; Ramagiri P; Ehrmann J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis at the NF1 locus in astrocytic brain tumors.
    Jensen S; Paderanga DC; Chen P; Olson K; Edwards M; Iavorone A; Israel MA; Shannon K
    Cancer; 1995 Aug; 76(4):674-7. PubMed ID: 8625164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early genetic changes involved in low-grade astrocytic tumor development.
    Arjona D; Rey JA; Taylor SM
    Curr Mol Med; 2006 Sep; 6(6):645-50. PubMed ID: 17022734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours.
    Hu J; Pang JC; Tong CY; Lau B; Yin XL; Poon WS; Jiang CC; Zhou LF; Ng HK
    Br J Cancer; 2002 Jul; 87(2):218-24. PubMed ID: 12107846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelotype of human malignant astrocytoma.
    Fults D; Pedone CA; Thomas GA; White R
    Cancer Res; 1990 Sep; 50(18):5784-9. PubMed ID: 1975510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary murine models in preclinical astrocytoma drug development.
    McNeill RS; Vitucci M; Wu J; Miller CR
    Neuro Oncol; 2015 Jan; 17(1):12-28. PubMed ID: 25246428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain.
    Chow LM; Endersby R; Zhu X; Rankin S; Qu C; Zhang J; Broniscer A; Ellison DW; Baker SJ
    Cancer Cell; 2011 Mar; 19(3):305-16. PubMed ID: 21397855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.
    Colin C; Baeza N; Bartoli C; Fina F; Eudes N; Nanni I; Martin PM; Ouafik L; Figarella-Branger D
    Oncogene; 2006 May; 25(19):2818-26. PubMed ID: 16314830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular biology and molecular genetics of astrocytic neoplasms.
    Wong AJ; Zoltick PW; Moscatello DK
    Semin Oncol; 1994 Apr; 21(2):139-48. PubMed ID: 8153660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.